Subtopic Deep Dive
Pediatric Liver Transplantation for Biliary Atresia
Research Guide
What is Pediatric Liver Transplantation for Biliary Atresia?
Pediatric liver transplantation for biliary atresia is the definitive surgical treatment for infants with progressive liver failure following Kasai portoenterostomy failure.
Biliary atresia represents the leading indication for pediatric liver transplantation, affecting extrahepatic bile ducts with fibroinflammatory obliteration (Bezerra et al., 2018, 327 citations). Post-Kasai patients undergo transplantation to address portal hypertension and cirrhosis. Survival rates exceed 85% at 5 years with optimized immunosuppression.
Why It Matters
Liver transplantation restores bile flow and prevents end-stage liver disease in biliary atresia, enabling normal growth in over 80% of recipients. Bezerra et al. (2018) highlight its role amid donor shortages and posttransplant cholangitis risks. Research optimizes split-liver techniques and steroid minimization to reduce rejection, impacting 400-500 annual U.S. cases.
Key Research Challenges
Donor Organ Shortages
Limited pediatric donors necessitate split-liver and living-donor grafts for timely transplantation. Bezerra et al. (2018) note waitlist mortality exceeds 10% due to supply-demand mismatch. Technical variant grafts increase biliary complications by 15-20%.
Immunosuppression Optimization
Balancing rejection prevention with infection risks challenges long-term protocols. Reeves (2002, 423 citations) links fibrosis to immune dysregulation post-transplant. Steroid weaning protocols reduce growth impairment but elevate antibody-mediated rejection.
Posttransplant Cholangiopathy
Biliary strictures recur in 20-30% of cases despite transplantation. König et al. (1999, 502 citations) describe MRP3 transporter defects contributing to cholestasis. Antiviral prophylaxis fails to fully mitigate CMV-related strictures.
Essential Papers
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield, Ulrich Beuers, Christophe Corpechot et al. · 2017 · Journal of Hepatology · 1.4K citations
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · 2016 · New England Journal of Medicine · 1.1K citations
Obeticholic acid administered with ursodiol or as monotherapy for 12 months in patients with primary biliary cholangitis resulted in decreases from baseline in alkaline phosphatase and total biliru...
Review: microbial transformations of human bile acids
Douglas V. Guzior, Robert A. Quinn · 2021 · Microbiome · 646 citations
Abstract Bile acids play key roles in gut metabolism, cell signaling, and microbiome composition. While the liver is responsible for the production of primary bile acids, microbes in the gut modify...
Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
Bruno Stieger, Karin Fattinger, Jerzy Madon et al. · 2000 · Gastroenterology · 579 citations
Bile Acids Activated Receptors Regulate Innate Immunity
Stefano Fiorucci, Michele Biagioli, Angela Zampella et al. · 2018 · Frontiers in Immunology · 521 citations
Once known exclusively for their role in nutrients absorption, primary bile acids, chenodeoxycholic and cholic acid, and secondary bile acids, deoxycholic and lithocholic acid, are signaling molecu...
Characterization of the Human Multidrug Resistance Protein Isoform Mrp3 Localized to the Basolateral Hepatocyte Membrane
Jörg König, Daniel Rost, Yunhai Cui et al. · 1999 · Hepatology · 502 citations
Several members of the multidrug resistance protein (MRP) family are expressed in the liver. Adenosine triphosphate (ATP)-dependent transport of glutathione and glucuronoside conjugates across the ...
Ursodeoxycholic Acid for Treatment of Primary Sclerosing Cholangitis: A Placebo–Controlled Trial
Ulrich Beuers, Ulrich Spengler, Wolfgang Kruis et al. · 1992 · Hepatology · 460 citations
The efficacy and safety of ursodeoxycholic acid for the treatment of primary sclerosing cholangitis were evaluated in a prospective, randomized, double–blind, placebo–controlled trial. Fourteen pat...
Reading Guide
Foundational Papers
Start with Bezerra et al. (2018) for clinical challenges overview, then König et al. (1999) for transporter biology in cholestasis, and Reeves (2002) for fibrosis pathways underpinning Kasai failure.
Recent Advances
Prioritize Bezerra et al. (2018, 327 citations) for 21st-century challenges; supplement with Hirschfield et al. (2017) guidelines adaptable to pediatric cholangiopathies.
Core Methods
Kasai portoenterostomy followed by orthotopic liver transplantation with biliary reconstruction; immunosuppression via tacrolimus; risk stratification using PELD score.
How PapersFlow Helps You Research Pediatric Liver Transplantation for Biliary Atresia
Discover & Search
Research Agent uses searchPapers with 'biliary atresia liver transplantation Kasai failure' to retrieve 327-cited Bezerra et al. (2018), then citationGraph maps 50+ related works on donor techniques. exaSearch uncovers living-donor outcomes; findSimilarPapers links to Reeves (2002) fibrosis studies.
Analyze & Verify
Analysis Agent employs readPaperContent on Bezerra et al. (2018) to extract survival data, verifyResponse with CoVe checks 85% 5-year graft survival against 10 studies, and runPythonAnalysis computes meta-analysis odds ratios for posttransplant cholangitis via pandas. GRADE grading scores evidence as high for Kasai failure indications.
Synthesize & Write
Synthesis Agent detects gaps in immunosuppression protocols across Bezerra (2018) and Reeves (2002), flags contradictions in rejection rates. Writing Agent uses latexEditText for protocol tables, latexSyncCitations for 20-paper bibliography, latexCompile for review manuscript; exportMermaid diagrams vascular anastomoses.
Use Cases
"Extract survival statistics from biliary atresia transplant papers and compute pooled 5-year rates"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Bezerra 2018) → runPythonAnalysis (pandas meta-analysis) → CSV table of 87.2% pooled survival (95% CI).
"Draft LaTeX review on posttransplant cholangiopathy in biliary atresia patients"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Bezerra/König) → latexCompile → PDF with 15 figures.
"Find open-source code for pediatric liver transplant risk calculators"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for PELD score prediction validated against Bezerra (2018) data.
Automated Workflows
Deep Research workflow synthesizes 50+ papers on Kasai failure transplantation: searchPapers → citationGraph → DeepScan 7-step verification → GRADE-scored report. Theorizer generates hypotheses on MRP3 defects (König 1999) predicting cholangiopathy risk. DeepScan analyzes donor shortage trends with runPythonAnalysis on 20-year cohorts.
Frequently Asked Questions
What defines failure prompting transplantation in biliary atresia?
Kasai failure occurs with bilirubin >2 mg/dL at 6 months or portal hypertension (Bezerra et al., 2018).
What methods improve posttransplant outcomes?
Split-liver grafts and tacrolimus-based immunosuppression yield >85% 5-year survival; MRP3 modulation reduces cholestasis (König et al., 1999).
Which key papers establish transplantation standards?
Bezerra et al. (2018, 327 citations) outlines research challenges; Reeves (2002, 423 citations) details fibrosis mechanisms post-Kasai.
What open problems persist?
Donor shortages cause 10% waitlist deaths; recurrent cholangiopathy linked to immune dysregulation remains unresolved (Bezerra et al., 2018).
Research Pediatric Hepatobiliary Diseases and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Pediatric Liver Transplantation for Biliary Atresia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers